A composite nanocarrier to inhibit precipitation of the weakly basic drug in the gastrointestinal tract
Chunli ZhengDepartment of Pharmaceutics, China Pharmaceutical University, Nanjing, ChinaYun LiDepartment of Pharmaceutics, China Pharmaceutical University, Nanjing, ChinaZhenwei PengDepartment of Pharmaceutics, China Pharmaceutical University, Nanjing, ChinaXinyi HeDepartment of Pharmaceutics, China Pharmaceutical University, Nanjing, ChinaJuan TaoLiang GeDepartment of Pharmaceutics, China Pharmaceutical University, Nanjing, ChinaYixin SunNanjing Children's Hospital, Nanjing Medical University, Nanjing, ChinaYunkai WuSchool of Basic Medical Sciences, Anhui Medical University, Hefei, China
2020en
ABI
Аннотация
.01) compared with the commercial formulation, indicating that the anticoagulant effect of DE was effectively improved. Therefore, the designed composite nanocarrier system of DE presents great potentials in improving the therapeutic efficiency and expanding the clinical applications of poorly water-soluble weakly basic drugs.
Ҳали таржима қилинмаган
Идентификаторлар
Иқтибослар ва манбалар
2 та иқтибос0 та фойдаланилган манба